These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7865953)

  • 1. Initiation of a fibrinolytic system in hepatic resection: the roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Shimada M; Matsumata T; Yamamoto K; Itasaka H; Taketomi A; Sugimachi K
    Surg Today; 1994; 24(9):780-4. PubMed ID: 7865953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K; Eguchi Y; Kodama M
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
    Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
    Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes.
    Agren A; Jörneskog G; Elgue G; Henriksson P; Wallen H; Wiman B
    Diabetes Care; 2014 Jul; 37(7):2007-14. PubMed ID: 24760258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
    Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
    Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis as a Causative Mechanism for Bleeding Complications on Extracorporeal Membrane Oxygenation: A Pilot Observational Prospective Study.
    Helms J; Curtiaud A; Severac F; Tschirhart M; Merdji H; Bourdin M; Contant G; Depasse F; Abou Rjeily R; Sattler L; Meziani F; Angles-Cano E
    Anesthesiology; 2024 Jul; 141(1):75-86. PubMed ID: 38502917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of retinal detachment surgery on perioperative blood fibrinolysis.
    Malukiewicz-Wiśniewska G; Kotschy M; Kałuzny J
    Curr Eye Res; 1999 Aug; 19(2):123-30. PubMed ID: 10420181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty Patients.
    Burleson A; Guler N; Banos A; Syed D; Wanderling C; Hoppensteadt D; Rees H; Fareed J; Hopkinson W
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):274-9. PubMed ID: 26460335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
    Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
    Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
    Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
    Sci Rep; 2021 Jan; 11(1):1580. PubMed ID: 33452298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
    Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic response to retinal detachment surgery under general or local anesthesia.
    Malukiewicz-Wiśniewska G; Kotschy M
    Eur J Ophthalmol; 2001; 11(1):66-72. PubMed ID: 11284489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.